PTO Finds Stem Cell Patent Anticipated, Obvious in Light of 'Significant Guideposts'
By Tony Dutra and Joyce Cutler,
The Bureau of National Affairs
| 05. 12. 2010
[Quotes CGS's Jesse Reynolds]
The Board of Patent Appeals and Interferences at the Patent and Trademark Office found April 28 that a patent on human embryonic stem cells was invalid as anticipated by an earlier patent and obvious in light of the "significant guideposts" in the literature for deriving the cells at the time of invention (
Foundation for Taxpayer and Consumer Rights v. Wisconsin Alumni Research Foundation, B.P.A.I., No. 2010-001854, 4/28/10).
The patent is one of three on stem cell derivation assigned to Wisconsin Alumni Research Foundation and licensed to Geron Corp. It was challenged by consumer advocacy groups in a PTO inter partes reexamination proceeding.
One of the challengers was also successful recently in the Myriad case challenging gene patenting on Section 101 grounds. A stakeholder in the biotechnology industry suggested that both cases represent a "pushback" against the "land rush" for intellectual property in the field.
Challenge by PUBPAT and Consumer Watchdog.
A patent (7,029,913) was issued April 18, 2006, to James A. Thomson titled "Primate embyronic stem cells," with claims drawn to pluripotent human embryonic stem, or ES, cells derived...
Related Articles
A Review of Exposed by Becky McClain
“Do not get lost in a sea of despair. Be hopeful, be optimistic. Our struggle is not the struggle of a day, a week, a month, or a year, it is the struggle of a lifetime. Never, ever be afraid to make some noise and get in good trouble, necessary trouble.”
— John Lewis
Becky McClain became famous when she successfully sued Pfizer, one of the very largest pharmaceutical and biotech companies. She...
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
By Carter Sherman, The Guardian | 12.08.2025
A huge defense policy bill, revealed by US lawmakers on Sunday, does not include a provision that would have provided broad healthcare coverage for in vitro fertilization (IVF) for active-duty members of the military, despite Donald Trump’s pledge...
